(NYSE:BHVN) LOS ANGELES, Sept. 2, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Biohaven Ltd. ("Biohaven" or the "Company") (NYSE: BHVN). IF YOU SUFFERED A LOSS ON YOUR BIOHAVEN...
Related Questions
How likely is the lawsuit to result in a material settlement or judgment that could affect Biohaven's valuation?
What is the expected timeline for the class action to progress and could it create near‑term volatility in BHVN shares?
How might this legal development influence institutional exposure and short‑selling activity in Biohaven compared to its peers?